The article deals with nowadays considerations concerning the pathogenesis of such systemic autoimmune disease as diffuse toxic goiter. The clinical monitoring of severe form of diffuse toxic goiter complicated by systemic autoimmune manifestations with characteristic alterations of results of clinical, biochemical, hormonal and immunologic analyses is analyzed.